| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.31 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |